157 related articles for article (PubMed ID: 37226638)
1. Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma.
Kawamura K; Miyai K; Sato K; Matsukuma S; Honda K; Ito K; Tsuda H
Cancer Sci; 2023 Aug; 114(8):3411-3422. PubMed ID: 37226638
[TBL] [Abstract][Full Text] [Related]
2. Tumor budding in upper urinary tract urothelial carcinoma: a putative prognostic factor for extraurothelial recurrence and overall survival.
Kawamura K; Miyai K; Asakuma J; Sato K; Matsukuma S; Tsuda H; Ito K
Virchows Arch; 2021 Jul; 479(1):45-55. PubMed ID: 33404852
[TBL] [Abstract][Full Text] [Related]
3. BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.
Yamamoto Y; Oga A; Akao J; Misumi T; Fuji N; Kobayashi K; Kawai Y; Inoue R; Hirata H; Matsumoto H; Nagao K; Sakano S; Matsuyama H
Jpn J Clin Oncol; 2016 Aug; 46(8):754-61. PubMed ID: 27174960
[TBL] [Abstract][Full Text] [Related]
4. Actinin-4 gene amplification in ovarian cancer: a candidate oncogene associated with poor patient prognosis and tumor chemoresistance.
Yamamoto S; Tsuda H; Honda K; Onozato K; Takano M; Tamai S; Imoto I; Inazawa J; Yamada T; Matsubara O
Mod Pathol; 2009 Apr; 22(4):499-507. PubMed ID: 19151661
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma.
Miyai K; Kawamura K; Ito K; Matsukuma S; Tsuda H
BMC Cancer; 2022 Jul; 22(1):787. PubMed ID: 35850759
[TBL] [Abstract][Full Text] [Related]
6. Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.
Noro R; Honda K; Tsuta K; Ishii G; Maeshima AM; Miura N; Furuta K; Shibata T; Tsuda H; Ochiai A; Sakuma T; Nishijima N; Gemma A; Asamura H; Nagai K; Yamada T
Ann Oncol; 2013 Oct; 24(10):2594-2600. PubMed ID: 23899839
[TBL] [Abstract][Full Text] [Related]
7. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
8. Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma.
Watabe Y; Mori T; Yoshimoto S; Nomura T; Shibahara T; Yamada T; Honda K
Cancer Med; 2014 Jun; 3(3):613-22. PubMed ID: 24574362
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer.
Kakuya T; Mori T; Yoshimoto S; Watabe Y; Miura N; Shoji H; Onidani K; Shibahara T; Honda K
Int J Oral Maxillofac Surg; 2017 Aug; 46(8):968-976. PubMed ID: 28385383
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
[TBL] [Abstract][Full Text] [Related]
11. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
Nishikawa M; Miyake H; Fujisawa M
Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
[TBL] [Abstract][Full Text] [Related]
12. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
13. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
[TBL] [Abstract][Full Text] [Related]
14. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Yamashita R; Watanabe R; Ito I; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
Int Urol Nephrol; 2017 Mar; 49(3):425-430. PubMed ID: 28078533
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
Morizane S; Iwamoto H; Masago T; Yao A; Isoyama T; Sejima T; Takenaka A
Int Urol Nephrol; 2013 Feb; 45(1):99-106. PubMed ID: 23229166
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
[TBL] [Abstract][Full Text] [Related]
18. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
[TBL] [Abstract][Full Text] [Related]
19. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
20. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
